Aquestive Therapeutics Inc (NAS:AQST)
$ 4.755 -0.395 (-7.67%) Market Cap: 432.99 Mil Enterprise Value: 414.81 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 53/100

Q4 2019 Aquestive Therapeutics Inc Earnings Call Transcript

Mar 12, 2020 / 12:00PM GMT
Release Date Price: $1.92 (-34.69%)
Operator

Good morning, and welcome to the Aquestive Therapeutics Fourth Quarter and Full Year 2019 Conference Call.

(Operator Instructions)

As a reminder, this call will be recorded. I would now like to introduce your host for today's conference, Ms. Stephanie Carrington, Westwicke Investor Relations. You may begin.

Stephanie Carrington
ICR, LLC - SVP

Thank you, operator. Good morning, and welcome to today's call to review Aquestive Therapeutics' Results for the Fourth Quarter and Full 2019 and Business Highlights. On today's call, I am joined by Keith Kendall, Chief Executive Officer; and John Maxwell, Chief Financial Officer, who are going to provide an overview of recent business developments and performance in the fourth quarter and full year. Additional members of the company's leadership team will be available for the Q&A. In total, we expect today's call to last approximately 60 minutes. As a reminder, our remarks today correspond with the earnings release we issued after market close yesterday.

In addition, a recording of today

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot